Napo Pharmaceuticals announced that the late-breaker abstract Napo submitted to MASCC on additional significant results in adult breast cancer patients from the OnTarget study has been accepted for ...

Research and Development: The R&D expense decreased by $2.1 million, from $18.6 million for the year ended December 31, 2023 compared to $16.5 million in 2024, primarily due to the conclusion of the ...

with additional POC IIT results expected throughout 2025 FDA meeting in the second quarter of 2025 on the statistically significant results of the Phase 3 OnTarget trial of crofelemer in the ...

The statistically significant responder analysis results for Mytesi ® (crofelemer) in the OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 ...

The statistically significant responder analysis results for Mytesi ® (crofelemer) in the OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 ...

One of the most exciting use cases for TAMS replay lies in live sports production. With Ateliere Live, content from multiple cameras can be ingested directly into a TAMS-compliant media store in ...

HOUSTON, TX / ACCESS Newswire / March 27, 2025 / CEC Energy is proud to announce the appointment of Danny Cook, former President of CEC (2012-2021), as Chief Executive Officer, effective immediately.

The statistically significant responder analysis results for Mytesi ® (crofelemer) in the OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 ...